We are live on ! Find out more
AGM

Alpine Global Management Portfolio holdings

AUM $668M
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
+24.13%
1 Year Est. Return
+20.22%
3 Year Est. Return
+100.14%
5 Year Est. Return
+103.13%
10 Year Est. Return
+677.44%
AUM
$765M
AUM Growth
+$352M
Cap. Flow
+$307M
Cap. Flow %
40.15%
Top 10 Hldgs %
58%
Holding
289
New
129
Increased
53
Reduced
15
Closed
77

Top Buys

Rank Stock Value
1
IMVT icon
Immunovant
IMVT
+$69.1M
2
CLM icon
Cornerstone Strategic Value Fund
CLM
+$56.1M
3
CRF
Cornerstone Total Return Fund
CRF
+$24.8M
4
ACHR icon
Archer Aviation
ACHR
+$19.8M
5
IWM icon
iShares Russell 2000 ETF
IWM
+$16.3M

Top Sells

Rank Stock Value
1
HOOD icon
Robinhood
HOOD
+$15.2M
2
MUI
BlackRock Municipal Income Fund, Inc.
MUI
+$9.11M
3
SRCL
Stericycle Inc
SRCL
+$6.69M
4
CTLT
CATALENT, INC.
CTLT
+$4.54M
5
UBER icon
Uber
UBER
+$3.3M

Sector Composition

Rank Sector Weight
1 Healthcare 16.13%
2 Industrials 10.96%
3 Financials 10%
4 Technology 4.85%
5 Communication Services 2.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TCPC icon
151
BlackRock TCP Capital
TCPC
$274M
$218K 0.03%
25,000
-4,200
-14% -$36.3K
AGNC icon
152
AGNC Investment
AGNC
$12.9B
$215K 0.03%
+23,328
New +$228K
NESR
153
National Energy Services Reunited Corp
NESR
$2.58B
$203K 0.03%
+22,688
New +$201K
PCF
154
High Income Securities Fund
PCF
$99.2M
$199K 0.03%
+30,546
New +$205K
BFLY icon
155
Butterfly Network
BFLY
$1.88B
$191K 0.03%
+61,150
New +$159K
AEF
156
abrdn Emerging Markets Equity Income Fund
AEF
$342M
$182K 0.02%
+35,000
New +$190K
BMTX.WS
157
DELISTED
BM Technologies, Inc. Warrants, each warrant exercisable for one share of Common Stock at an exercise price of $11.50
BMTX.WS
$170K 0.02%
+292,132
New +$115K
ILLR
158
Triller Group Inc
ILLR
$18.9M
$167K 0.02%
+7,002
New +$255K
ATYR
159
aTyr Pharma
ATYR
$48.4M
$126K 0.02%
+34,858
New +$106K
CRVS icon
160
Corvus Pharmaceuticals
CRVS
$1.12B
$125K 0.02%
+23,282
New +$174K
PSNL icon
161
Personalis
PSNL
$1.27B
$120K 0.02%
+20,824
New +$96.1K
ELDN icon
162
Eledon Pharmaceuticals
ELDN
$262M
$111K 0.01%
+26,942
New +$106K
WBX
163
Wallbox
WBX
$83.5M
$109K 0.01%
+10,867
New +$172K
RZLT icon
164
Rezolute
RZLT
$474M
$108K 0.01%
+22,114
New +$111K
IKT icon
165
Inhibikase Therapeutics
IKT
$363M
$96.5K 0.01%
+29,684
New +$74K
AMLX icon
166
Amylyx Pharmaceuticals
AMLX
$2.17B
$90.8K 0.01%
+24,034
New +$113K
CIA icon
167
Citizens
CIA
$257M
$81.8K 0.01%
+20,410
New +$91.8K
GGR icon
168
Gogoro
GGR
$60.6M
$80.4K 0.01%
+8,043
New +$86.8K
EXFY icon
169
Expensify
EXFY
$173M
$79.2K 0.01%
+23,640
New +$63.6K
ZTR
170
Virtus Total Return Fund
ZTR
$340M
$79.1K 0.01%
+13,500
New +$81.2K
PRQR icon
171
ProQR Therapeutics
PRQR
$248M
$78.2K 0.01%
+29,498
New +$93.7K
ACRS icon
172
Aclaris Therapeutics
ACRS
$744M
$76.1K 0.01%
+30,680
New +$76.3K
TPIC
173
DELISTED
TPI Composites
TPIC
$75.7K 0.01%
+40,058
New +$111K
QSI icon
174
Quantum-Si Incorporated
QSI
$166M
$74.4K 0.01%
+27,570
New +$32.3K
RVNC
175
DELISTED
Revance Therapeutics, Inc.
RVNC
$74.2K 0.01%
+24,404
New +$106K
5 6
7
8 9

Similar funds

IACCIA
IDG-Accel China Capital II Associates Palo Alto, California $667M AUM
TAP
TSG Advice Partners Columbus, Ohio $667M AUM
CWP
CFM Wealth Partners Austin, Texas $667M AUM 27.85% 1-Year Est. Return
WSCM
Wellington Shields Capital Management New York $666M AUM 45.43% 1-Year Est. Return
AO
Allen Operations New York $670M AUM 26.43% 1-Year Est. Return
BCP
Bain Capital Prairie Boston, Massachusetts $666M AUM
SP
Summit Partners Boston, Massachusetts $670M AUM 6.71% 1-Year Est. Return
LCM
Lonestar Capital Management San Francisco, California $671M AUM 72.56% 1-Year Est. Return

Alpine Global Management's Q4 2024 Portfolio in Review

As of Q4 2024, Alpine Global Management held 289 positions worth $765M, up 85% from $413M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Alpine Global Management deployed $307M of net new capital in Q4 2024, opening 129 new positions and adding to 53 existing holdings. Its largest new stake was Cartesian Growth Corp II: 400,000 shares worth $4.66M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Robinhood, an estimated $15.2M trimmed.

  • Alpine Global Management's largest Q4 2024 buy was Cartesian Growth Corp II: 400,000 shares worth $4.66M.
  • Alpine Global Management added most to Immunovant in Q4 2024, an estimated $69.1M increase.
  • Alpine Global Management's biggest Q4 2024 reduction was Robinhood, cutting an estimated $15.2M.
  • Alpine Global Management fully exited BlackRock Municipal Income Fund, Inc. in Q4 2024, selling an estimated $9.11M.
  • Alpine Global Management's ten largest holdings make up 58% of its $765M portfolio in Q4 2024.
  • Alpine Global Management opened 129 new positions and closed 77 in Q4 2024.
  • Alpine Global Management's portfolio value rose 85% quarter-over-quarter to $765M.

Based on Alpine Global Management's 13F filing for Q4 2024, filed 14 Feb 2025.